SCHEMBL17295632

SCHEMBL17295632

CCCCN1C(=O)C(=Cc2ccc3[nH]cnc3c2)SC1=Nc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.57
▸ HPGD P15428 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ FAAH O00519 1/20 0.55
▸ CA9 Q16790 13/20 0.47
▸ CA2 P00918 1/20 0.47
▸ AKR1B1 P15121 1/20 0.45
▸ PTPN1 P18031 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295631 1.00 LMNA (0.57) LMNAHPGDSMN1; SMN2FAAHCA9
SCHEMBL17295442 0.90 LMNA (0.49) LMNAHPGDSMN1; SMN2FAAHCA9
SCHEMBL17295441 0.90 LMNA (0.49) LMNAHPGDSMN1; SMN2FAAHCA9
SCHEMBL17295448 0.88 ALDH1A1 (0.51) LMNAHPGDSMN1; SMN2FAAHCA9
SCHEMBL17295444 0.88 ALDH1A1 (0.51) LMNAHPGDSMN1; SMN2FAAHCA9
SCHEMBL17295403 0.86 CA9 (0.60) CA9CA2PTPN1
SCHEMBL17295405 0.86 CA9 (0.60) CA9CA2PTPN1
SCHEMBL17302191 0.84 FAAH (0.57) LMNAHPGDSMN1; SMN2FAAHCA9
SCHEMBL17295388 0.82 FAAH (0.62) LMNASMN1; SMN2FAAHCA9CA2
SCHEMBL17302192 0.82 FAAH (0.62) LMNASMN1; SMN2FAAHCA9CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback